Method of Treating Malignant Mesothelioma
The present invention relates to a therapeutic agent for malignant mesothelioma comprising a substance which inhibits binding of CD26 to extracellular matrix such as an siRNA targeting CD26 cDNA or an anti-CD26 antibody. The present invention also relates to a method of treating malignant mesothelioma, which comprises administering the substance to a patient in need thereof.
The present invention relates to a therapeutic agent for malignant mesothelioma and a method of treating malignant mesothelioma.
Patents:US 20,100,135,993
Inventor(s):
MORIMOTO CHIKAO [JP]; OHNUMA KEI [JP]; INAMOTO TERUO [JP]
Type of Offer:
Sale
« More Medical Patents